ScholarIQanswers from OpenAlex

MicroRNA-30e regulates neuroinflammation in MPTP model of Parkinson’s disease by targeting Nlrp3

PaperCitations, authors & open-access status

MicroRNA-30e regulates neuroinflammation in MPTP model of Parkinson’s disease by targeting Nlrp3 is a paper indexed in ScholarIQ from OpenAlex.

How many citations does MicroRNA-30e regulates neuroinflammation in MPTP model of Parkinson’s disease by targeting Nlrp3 have?

ScholarIQcitation count

MicroRNA-30e regulates neuroinflammation in MPTP model of Parkinson’s disease by targeting Nlrp3 has 137 citations in the OpenAlex counts ScholarIQ stores.

When was MicroRNA-30e regulates neuroinflammation in MPTP model of Parkinson’s disease by targeting Nlrp3 published?

ScholarIQyear

MicroRNA-30e regulates neuroinflammation in MPTP model of Parkinson’s disease by targeting Nlrp3 has 2017 year in the ScholarIQ index.

What is the open-access status of MicroRNA-30e regulates neuroinflammation in MPTP model of Parkinson’s disease by targeting Nlrp3?

ScholarIQoa status

MicroRNA-30e regulates neuroinflammation in MPTP model of Parkinson’s disease by targeting Nlrp3 has hybrid oa status in the ScholarIQ index.

What is the DOI of MicroRNA-30e regulates neuroinflammation in MPTP model of Parkinson’s disease by targeting Nlrp3?

ScholarIQdoi

The DOI for MicroRNA-30e regulates neuroinflammation in MPTP model of Parkinson’s disease by targeting Nlrp3 is on the source record.

What is the PMID of MicroRNA-30e regulates neuroinflammation in MPTP model of Parkinson’s disease by targeting Nlrp3?

ScholarIQpmid

The PMID for MicroRNA-30e regulates neuroinflammation in MPTP model of Parkinson’s disease by targeting Nlrp3 is on the source record.

What is the OpenAlex record for MicroRNA-30e regulates neuroinflammation in MPTP model of Parkinson’s disease by targeting Nlrp3?

ScholarIQopenalex

The OpenAlex for MicroRNA-30e regulates neuroinflammation in MPTP model of Parkinson’s disease by targeting Nlrp3 is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial